Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Neurotron Biotechnology

Request full access

Neurotron Biotechnology is a China-based medical device company developing spine-related products

Hangzhou, ChinaFounded 2006

About Neurotron Biotechnology

Neurotron Biotechnology, founded in 2006, is a medical device company focused on designing, developing, and marketing neurostimulation systems to address profound hearing loss. The company's main offering is the Venus Cochlear Implant System, a solution for both adults and children. This system represents a significant milestone as the first commercially available, affordable cochlear implant to provide high performance comparable to existing, more expensive devices.

The development of the Nurotron device was driven by the significant unmet need for affordable cochlear implants, particularly in low- and middle-income countries. In China alone, where the company is based, there are millions of individuals with deafness, but only a small fraction have received implants due to high costs. Neurotron successfully addressed this by drastically reducing the unit cost, making the technology more accessible. For instance, through the Chinese Government Tender Program, the price dropped from US$25,000 in 2011 to US$4,620 in 2017.

The company's Venus Cochlear Implant features a 22 mm electrode array with 24 intracochlear electrodes. It has received China FDA approval in 2011 and the European CE marking in 2012, and is also approved for sale in Colombia, India, Turkey, and Venezuela. While the company has a research and development center in Irvine, California, the Venus system is not yet FDA-approved for the U.S. market. Neurotron also manufactures its systems in a large complex in Zhejiang Hangzhou, China. Beyond cochlear implants, the company is also developing other neurostimulation solutions, including auditory brainstem implants, artificial vision systems, and treatments for paralysis.

Source: Dealroom company data

Neurotron Biotechnology in the Hangzhou ecosystem

Live from Dealroom

The Neurotron Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Neurotron Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Neurotron Biotechnology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.